OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Successful Treatment of Persistent SARS-CoV-2 Infection in a B-Cell Depleted Patient with Activated Cytotoxic T and NK Cells: A Case Report
Jacek Jassem, Natalia Marek-Trzonkowska, Tomasz Smiatacz, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 10934-10934
Open Access | Times Cited: 9
Jacek Jassem, Natalia Marek-Trzonkowska, Tomasz Smiatacz, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 10934-10934
Open Access | Times Cited: 9
Showing 9 citing articles:
COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis
Jonathon W. Senefeld, Massimo Franchini, Carlo Mengoli, et al.
JAMA Network Open (2023) Vol. 6, Iss. 1, pp. e2250647-e2250647
Open Access | Times Cited: 127
Jonathon W. Senefeld, Massimo Franchini, Carlo Mengoli, et al.
JAMA Network Open (2023) Vol. 6, Iss. 1, pp. e2250647-e2250647
Open Access | Times Cited: 127
SARS-CoV-2 in immunocompromised individuals
Susan DeWolf, Justin C. Laracy, Miguel‐Angel Perales, et al.
Immunity (2022) Vol. 55, Iss. 10, pp. 1779-1798
Open Access | Times Cited: 88
Susan DeWolf, Justin C. Laracy, Miguel‐Angel Perales, et al.
Immunity (2022) Vol. 55, Iss. 10, pp. 1779-1798
Open Access | Times Cited: 88
Treatment of persistent COVID-19 in two B-cell-depleted patients with the monoclonal antibody Sotrovimab
David Totschnig, Daniel Doberer, Renate Haberl, et al.
IDCases (2022) Vol. 29, pp. e01528-e01528
Open Access | Times Cited: 10
David Totschnig, Daniel Doberer, Renate Haberl, et al.
IDCases (2022) Vol. 29, pp. e01528-e01528
Open Access | Times Cited: 10
COVID-19 convalescent plasma for the treatment of immunocompromised patients: a systematic review
Jonathon W. Senefeld, Massimo Franchini, Carlo Mengoli, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 10
Jonathon W. Senefeld, Massimo Franchini, Carlo Mengoli, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 10
What Inhibits Natural Killers’ Performance in Tumour
Ines Papak, Elżbieta Chruściel, Katarzyna Dziubek, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7030-7030
Open Access | Times Cited: 8
Ines Papak, Elżbieta Chruściel, Katarzyna Dziubek, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7030-7030
Open Access | Times Cited: 8
Overview of Memory NK Cells in Viral Infections: Possible Role in SARS-CoV-2 Infection
Juan Bautista De Sanctis, Jenny Garmendia, Marián Hajdúch
Immuno (2022) Vol. 2, Iss. 1, pp. 52-67
Open Access | Times Cited: 5
Juan Bautista De Sanctis, Jenny Garmendia, Marián Hajdúch
Immuno (2022) Vol. 2, Iss. 1, pp. 52-67
Open Access | Times Cited: 5
Special Issue “Molecular and Genetic Aspects of SARS-CoV-2 Infection and COVID-19 Disease”
Fernando Cardona, Jordi Pérez‐Tur
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4670-4670
Open Access
Fernando Cardona, Jordi Pérez‐Tur
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4670-4670
Open Access
Combination Therapies against COVID-19
Qunfeng Luo, Yunxi Zheng, Jin Zhang
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 9
Open Access | Times Cited: 2
Qunfeng Luo, Yunxi Zheng, Jin Zhang
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 9
Open Access | Times Cited: 2
